Progyny, Inc. Net Debt/EBITDA

Net Debt/EBITDA of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending June 30, 2022 was -12.51 (a -96.11% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA increased by 10.76%
  • Annual Net Debt/EBITDA for 2021 was -3.29 (a -66.57% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was -9.85 (a 44.69% increase from previous year)
  • Annual Net Debt/EBITDA for 2019 was -6.81 (a -89.96% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Progyny, Inc.

Most recent Net Debt/EBITDAof PGNY including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Progyny, Inc.

Progyny, Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -12.51 -321.85
2021 -865.38 -11.3 -7.1 -7.98 -3.29
2020 -62.14 -19.84 149.31 -23.19 -9.85
2019 -47.76 -2.13 0.97 0.0 -6.81
2018 0.0 0.0 -67.79
2017 0.0 -11.52

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services